| pubmed-article:6142539 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C1522642 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C0204727 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C0883208 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C1519697 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:6142539 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:6142539 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:6142539 | pubmed:dateCreated | 1984-4-6 | lld:pubmed |
| pubmed-article:6142539 | pubmed:abstractText | We have used a positive immunoselection method to isolate a Thy-1-positive revertant of a Thy-1-negative line. The technique makes use of the ability of surface bound antigen-antibody complexes containing the enzyme catalase to protect cells from the toxic effects of hydrogen peroxide. The revertant cells produce a Thy-1 molecule indistinguishable from that produced by the original parent line, and they resemble that line in being far more tumorigenic than the Thy-1-negative variant. | lld:pubmed |
| pubmed-article:6142539 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6142539 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6142539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6142539 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6142539 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:6142539 | pubmed:issn | 0740-7750 | lld:pubmed |
| pubmed-article:6142539 | pubmed:author | pubmed-author:BaschR SRS | lld:pubmed |
| pubmed-article:6142539 | pubmed:author | pubmed-author:BuxbaumJ NJN | lld:pubmed |
| pubmed-article:6142539 | pubmed:author | pubmed-author:TengMM | lld:pubmed |
| pubmed-article:6142539 | pubmed:author | pubmed-author:LakosAA | lld:pubmed |
| pubmed-article:6142539 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6142539 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:6142539 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6142539 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6142539 | pubmed:pagination | 37-44 | lld:pubmed |
| pubmed-article:6142539 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:meshHeading | pubmed-meshheading:6142539-... | lld:pubmed |
| pubmed-article:6142539 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6142539 | pubmed:articleTitle | Isolation of highly malignant Thy-1-positive revertants from cultured cloned Thy-1-negative lymphoma cells of low tumorigenicity. | lld:pubmed |
| pubmed-article:6142539 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6142539 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6142539 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:6142539 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6142539 | lld:pubmed |
